CGTX
Cognition Therapeutics Inc

3,969
Loading...
Loading...
News
all
press releases
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
PURCHASE, N.Y., April 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the Company or Cognition ) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
Globe Newswire·1y ago
News Placeholder
More News
News Placeholder
Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the Company or Cognition ) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
Globe Newswire·1y ago
News Placeholder
B. Riley Reiterates "Buy" Rating for Cognition Therapeutics (NASDAQ:CGTX)
Cognition Therapeutics (NASDAQ:CGTX - Get Free Report)s stock had its "buy" rating restated by investment analysts at B. Riley in a research note issued on Thursday, Benzinga reports. They...
Zolmax·1y ago
News Placeholder
Q4 2023 Cognition Therapeutics Inc Earnings Call Transcript
Related Stocks: NAS:CGTX...
GuruFocus·1y ago
News Placeholder
Cognition Therapeutics reports FY results
Cognition Therapeutics reports FY results...
SeekingAlpha.com: All News·1y ago
News Placeholder
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
- Topline Results from SHINE Study in Mild-to-Moderate Alzheimer's Expected mid-2024 -- On Track to Report Topline Results from SHIMMER Study in Mild-to-Moderate DLB in 2H 2024 - - 1Q 2024 Capital...
Globe Newswire·1y ago
News Placeholder
A Preview Of Cognition Therapeutics's Earnings
read more...
Benzinga·1y ago
News Placeholder
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
Conference Call and Live Audio Webcast Scheduled for March 26, 2024PURCHASE, N.Y., March 15, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience...
Globe Newswire·2y ago
News Placeholder
Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Benzinga·2y ago
News Placeholder
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
PURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. ( Cognition, the Company or We ) (Nasdaq: CGTX), a clinical stage company developing product candidates designed...
Globe Newswire·2y ago

Latest CGTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.